EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition

Y Mahamat-Saleh iD, S Rinaldi iD, R Kaaks, C Biessy, E M Gonzalez-Gil, N Murphy, C Le Cornet, J M Huerta iD, S Sieri, A Tjønneland, L Mellemkjaer iD, M Guevara und 19 weitere

Cancer Medicine · 2023

DOI: 10.1002/cam4.5896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Y Mahamat-Saleh und 30 weiteren Autor:innen. Beteiligte Einrichtung: International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Overweight, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Excess body fatness and hyperinsulinemia are both associated with an increased risk of postmenopausal breast cancer. However, whether women with high body fatness but normal insulin levels or those with normal body fatness and high levels of insulin are at elevated risk of breast cancer is not known. We investigated the associations of metabolically defined body size and shape phenotypes with the risk of postmenopausal breast cancer in a nested case–control study within the European Prospective Investigation into Cancer and Nutrition.

Methods

Concentrations of C‐peptide—a marker for insulin secretion—were measured at inclusion prior to cancer diagnosis in serum from 610 incident postmenopausal breast cancer cases and 1130 matched controls. C‐peptide concentrations among the control participants were used to define metabolically healthy (MH; in first tertile) and metabolically unhealthy (MU; >1st tertile) status. We created four metabolic health/body size phenotype categories by combining the metabolic health definitions with normal weight (NW; BMI < 25 kg/m 2 , or WC < 80 cm, or WHR < 0.8) and overweight or obese (OW/OB; BMI ≥ 25 kg/m 2 , or WC ≥ 80 cm, or WHR ≥ 0.8) status for each of the three anthropometric measures separately: (1) MHNW, (2) MHOW/OB, (3) MUNW, and (4) MUOW/OB. Conditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs).

Results

Women classified as MUOW/OB were at higher risk of postmenopausal breast cancer compared to MHNW women considering BMI (OR = 1.58, 95% CI = 1.14–2.19) and WC (OR = 1.51, 95% CI = 1.09–2.08) cut points and there was also a suggestive increased risk for the WHR (OR = 1.29, 95% CI = 0.94–1.77) definition. Conversely, women with the MHOW/OB and MUNW were not at statistically significant elevated risk of postmenopausal breast cancer risk compared to MHNW women.

Conclusion

These findings suggest that being overweight or obese and metabolically unhealthy raises risk of postmenopausal breast cancer while overweight or obese women with normal insulin levels are not at higher risk. Additional research should consider the combined utility of anthropometric measures with metabolic parameters in predicting breast cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OverweightNeoplasmsFemaleHumansRisk FactorsSomatotypesPostmenopauseC-PeptideCase-Control StudiesProspective StudiesObesityPhenotypeBody SizeBody Mass Index

Stichwörter der Autor:innen

body mass indexbreast cancerconcentrations of C-peptidemetabolic healthwaist circumferencewaist-to-hip ratio

Substanzen

C-Peptide

Autor:innen und Institutionen

  • International Agency for Research on Cancer, Lyon, France.
  • Division of Cancer Epidemiology, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.
  • CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133, Milan, Italy.
  • Danish Cancer Society Research Center, Copenhagen, Denmark.

ORCID-Profile: Y Mahamat-Saleh, S Rinaldi, J M Huerta, L Mellemkjaer, A Perez-Cornago, S Tin Tin, S Christakoudi, A K Heath, K Tsilidis, S Severi, E Weiderpass

Förderung

  • World Health Organization
  • Cancer Research UK
  • Medical Research Council
  • Cancer Research UK Manchester Centre
  • Centre International de Recherche sur le Cancer
  • Danish Cancer Society Research Center
  • Bundesministerium für Bildung und Forschung
  • Fondation ARC pour la Recherche sur le Cancer

Zitieren

APA

Mahamat-Saleh, Y., Rinaldi, S., Kaaks, R., Biessy, C., Gonzalez-Gil, E. M., Murphy, N., Le Cornet, C., Huerta, J. M., Sieri, S., Tjønneland, A., Mellemkjaer, L., Guevara, M., Overvad, K., Perez-Cornago, A., Tin Tin, S., Padroni, L., Simeon, V., Masala, G., May, A., …, & Dossus, L. (2023). Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Medicine. https://doi.org/10.1002/cam4.5896

Vancouver

Mahamat-Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez-Gil EM, Murphy N, et al. Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Medicine. 2023. doi:10.1002/cam4.5896

BibTeX
@article{MahamatSaleh2023,
  author = {Mahamat-Saleh, Y and Rinaldi, S and Kaaks, R and Biessy, C and Gonzalez-Gil, E M and Murphy, N and Le Cornet, C and Huerta, J M and Sieri, S and Tjønneland, A and Mellemkjaer, L and Guevara, M and Overvad, K and Perez-Cornago, A and Tin Tin, S and Padroni, L and Simeon, V and Masala, G and May, A and Monninkhof, E and Christakoudi, S and Heath, A K and Tsilidis, K and Agudo, A and Schulze, M B and Rothwell, J and Cadeau, C and Severi, S and Weiderpass, E and Gunter, M J and Dossus, L},
  title = {Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5896}
}
Kostenlos starten →